Lancet neurology

The most recent articles from: Lancet Neurol September 2014

Lancet neurology · Sep 2014

Randomized Controlled Trial Multicenter Study

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.

Cervical dystonia is managed mainly by repeated botulinum toxin injections. We aimed to establish whether pallidal neurostimulation could improve symptoms in patients not adequately responding to chemodenervation or oral drug treatment. ⋯ Medtronic.

read on… or not…
Lancet neurology · Sep 2014

Randomized Controlled Trial Multicenter Study

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.

Migraine remains poorly treated, with few effective preventive drugs available. We assessed the safety and efficacy of LY2951742, a fully humanised monoclonal antibody to calcitonin gene-related peptide, for migraine prevention. ⋯ Arteaus Therapeutics.

read on… mark as read…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.